Search - Université Paris Cité Access content directly

Filter your results

11 Results
authFullName_s : Vincent Hautefeuille
Image document

Chemotherapy in advanced pancreatic adenosquamous carcinoma: A retrospective multicenter AGEO study

Marie Auvray Kuentz , Vincent Hautefeuille , Louis de Mestier , Clelia Coutzac , Thierry Lecomte et al.
International Journal of Cancer, 2023, ⟨10.1002/ijc.34414⟩
Journal articles hal-03969427v1

Endoscopic management of 345 small rectal neuroendocrine tumours: A national study from the French group of endocrine tumours (GTE)

Caroline Fine , Guillaume Roquin , Eric Terrebonne , Thierry Lecomte , Romain Coriat et al.
United European Gastroenterology Journal, 2019, 7 (8), pp.1102-1112. ⟨10.1177/2050640619861883⟩
Journal articles hal-02549178v1

Prognosis and chemosensitivity of non-V600E BRAF mutations in metastatic colorectal carcinoma (mCRC): An AGEO French multicenter retrospective cohort.

Aline Derosiere , Vincent Nicolai , David Malka , Astrid Pozet , Julien Lazartigues et al.
Journal of Clinical Oncology, 2019, 37 (15, S), ⟨10.1200/JCO.2019.37.15\_suppl.3575⟩
Journal articles hal-03606012v1
Image document

Pembrolizumab with Capox Bevacizumab in patients with microsatellite stable metastatic colorectal cancer and a high immune infiltrate: The FFCD 1703-POCHI trial

Claire Gallois , Jean-François Emile , Stefano Kim , Carole Monterymard , Marine Gilabert et al.
Digestive and Liver Disease, 2021, 53 (10), pp.1254-1259. ⟨10.1016/j.dld.2021.06.009⟩
Journal articles hal-03283091v1
Image document

Three fluoropyrimidine-based regimens in routine clinical practice after nab-paclitaxel plus gemcitabine for metastatic pancreatic cancer: An AGEO multicenter study

Anne-Laure Pointet , David Tougeron , Simon Pernot , Astrid Pozet , Dominique Béchade et al.
Clinics and Research in Hepatology and Gastroenterology, 2020, 44, pp.295 - 301. ⟨10.1016/j.clinre.2019.08.009⟩
Journal articles hal-03491049v1

Folfirinox versus gemcitabine/nab-paclitaxel as first-line therapy in patients with metastatic pancreatic cancer: a comparative propensity score study

Nicolas Williet , Angélique Saint , Anne-Laure Pointet , David Tougeron , Simon Pernot et al.
Therapeutic Advances in Gastroenterology, 2019, 12, pp.175628481987866. ⟨10.1177/1756284819878660⟩
Journal articles hal-02532994v1
Image document

Prognostic factors of colorectal cancer patients with brain metastases

Pauline Roussille , Marie Auvray , Damien Vansteene , Thierry Lecomte , Eugénie Rigault et al.
Radiotherapy & Oncology, 2021, 158, pp.67-73. ⟨10.1016/j.radonc.2021.02.006⟩
Journal articles hal-03237457v1

Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study

Sonia Zaibet , Vincent Hautefeuille , Edouard Auclin , Astrid Lièvre , David Tougeron et al.
British Journal of Cancer, 2022, 126 (10), pp.1394-1400. ⟨10.1038/s41416-022-01713-w⟩
Journal articles hal-03555280v1

Prognosis and chemosensitivity of non-colorectal alimentary tract cancers with microsatellite instability

Claire Boyer , David Sefrioui , Romain Cohen , Romain Chautard , Marine Perrier et al.
Digestive and Liver Disease, 2022, ⟨10.1016/j.dld.2022.03.011⟩
Journal articles hal-03731980v1

Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort

T. Walter , T Tougeron , Emmanuel Baudin , K. Le Malicot , T. Lecomte et al.
European Journal of Cancer, 2017, 79, pp.158 - 165. ⟨10.1016/j.ejca.2017.04.009⟩
Journal articles hal-01609152v1
Image document

Treatment, outcome, and prognostic factors in non-metastatic anal cancer: The French nationwide cohort study FFCD-ANABASE

Véronique Vendrely , Claire Lemanski , Pascal Pommier , Karine Le Malicot , Angélique Saint et al.
Radiotherapy & Oncology, 2023, 183, pp.109542. ⟨10.1016/j.radonc.2023.109542⟩
Journal articles hal-04016479v1